Mannosidosis

Mannosidosis
Electron micrograph of a vacuolated lymphocyte from a mannosidosis patient (A) as compared to a lymphocyte from a normal control (B).
SpecialtyPediatrics, endocrinology Edit this on Wikidata

Mannosidosis is a deficiency in mannosidase, an enzyme.[1] There are two types: alpha-mannosidosis and beta-mannosidosis. Both disorders are related to the lysosome and have similar presentation; the former is caused by defective lysosomal α-mannosidase and the latter by defective lysosomal β-mannosidase. In both cases, the defect causes accumulation of oligosaccharides rich in mannose[2] in the neural tissue and organ tissue.[3] Both alpha- and beta-mannosidosis are known to result from autosomal recessive genetic mutations.[4]

Alpha-mannosidosis

Main article: Alpha-mannosidosis

Alpha-mannosidosis is an inherited lysosomal storage disease that causes hearing loss, intellectual disability, facial and skeletal abnormalities, and immunological deficiencies. The main characteristics include skeletal abnormalities, hearing impairment, gradual impairment of mental functions and speech, and frequent periods of psychosis. Immune deficiency is manifested by recurrent infections, especially in the first decade of life. Autosomal recessive mutations in the MAN2B1 gene, which is situated on chromosome 19 (19 p13.2-q12), are the cause of alpha-mannosidosis. Acid alpha-mannosidase activity within leukocytes or other nucleated cells is used to make the diagnosis, which can then be verified by genetic testing.[5]

Beta-mannosidosis

Main article: Beta-mannosidosis

Beta-mannosidosis is an extremely rare metabolic storage disease caused by a deficiency of the enzyme beta-mannosidase, which is involved in the breakdown of glycoproteins. The clinical manifestation can range from mild to severe and includes symptoms like hearing loss, mental retardation, hyperactivity, behavioral issues, and recurrent respiratory and skin infections.[6]

See also

References

  1. ^ Mannosidosis at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  2. ^ Ellison, David; Love, Seth; Chimelli, Leila; Harding, Brian N.; Lowe, James S.; Vinters, Harry V.; Brandner, Sebastian; Yong, William H. (2013), "Lysosomal and peroxisomal disorders", Neuropathology, Elsevier, pp. 479–498, doi:10.1016/b978-0-7234-3515-0.00023-4, ISBN 978-0-7234-3515-0, retrieved 2024-01-03
  3. ^ Ming, Jeffrey E.; Graham, John M. (2014-01-01), Sullivan, Kathleen E.; Stiehm, E. Richard (eds.), "Chapter 12 - Genetic Syndromes with Evidence of Immune Deficiency", Stiehm's Immune Deficiencies, Amsterdam: Academic Press, pp. 281–324, doi:10.1016/b978-0-12-405546-9.00012-1, ISBN 978-0-12-405546-9, retrieved 2024-01-03
  4. ^ Malm, Dag; Nilssen, Øivind (December 2008). "Alpha-mannosidosis". Orphanet Journal of Rare Diseases. 3 (1): 21. doi:10.1186/1750-1172-3-21. ISSN 1750-1172. PMC 2515294. PMID 18651971.
  5. ^ Malm, Dag; Nilssen, Øivind (2008). "Alpha-mannosidosis". Orphanet Journal of Rare Diseases. 3 (1): 21. doi:10.1186/1750-1172-3-21. ISSN 1750-1172. PMC 2515294. PMID 18651971.
  6. ^ Safka Brozkova, Dana; Varga, Lukas; Uhrova Meszarosova, Anna; Slobodova, Zuzana; Skopkova, Martina; Soltysova, Andrea; Ficek, Andrej; Jencik, Jan; Lastuvkova, Jana; Gasperikova, Daniela; Seeman, Pavel (2020). "Variant c.2158-2A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant". Orphanet Journal of Rare Diseases. 15 (1): 222. doi:10.1186/s13023-020-01508-3. ISSN 1750-1172. PMC 7448337. PMID 32847582.